相关实验视频
Updated: Jun 3, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
一个非常低碳水化合物计划在成年人与代谢功能障碍相关的肥胖性肝病和脂酶域含蛋白3风险基因型:前后干预研究研究
Laura R Saslow1, Jamie Krinock1, Alison O'Brien1
1Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, United States.
一种非常低碳水化合物 (VLC) 饮食干预措施显示,在遗传倾向于发生与代谢功能障碍相关的脂肪性肝病的个体中,有望减少肝脏脂肪和体重. 这项研究强调了饮食.
科学领域:
- 代谢健康和遗传倾向.
- 肝脏疾病的营养干预措施.
背景情况:
- 胰岛素耐药性和rs738409 G等位基因增加了与代谢功能障碍相关的脂肪性肝病 (MASLD) 的风险.
- 遗传因素在MASLD的发展中发挥着作用.
研究的目的:
- 调查非常低碳水化合物 (VLC) 饮食模式在降低胰岛素耐药性的有效性.
- 评估VLC饮食对危险人群肝脂肪酸和代谢标志物的影响.
主要方法:
- 具有rs738409-GG或-CG基因型,肝脂肪炎和肝功能升高测试的成年人接受了为期4个月的VLC饮食干预.
- 干预包括关于VLC饮食,正念饮食,目标设定和通过指导自我监测的教育.
- 测量包括肝硬化症,人体测量,血清代谢标志物,饮食坚持和生活质量.
主要成果:
- 报告说,干预的满意度很高,许多参与者打算继续VLC饮食.
- 坚持的参与者显示肝脏脂肪显著减少 (53.12%).
- 所有参与者都实现了显著的体重减轻 (≥5%),75%的受访者满足了减少肝脂肪的标准.
结论:
- 这种VLC饮食干预似乎是可行的,可以接受的,并且在患有MASLD的遗传风险的成年人中表现出初步的疗效.
- 进一步的研究是有必要的,因为小样本大小和潜在的偏见在这个试点研究.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
相关概念视频
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inborn Errors of Metabolism
Chronic Pancreatitis II: Collaborative Care
Assessment:
Lipid-Lowering Drugs: Statins and Miscellaneous Agents